Literature DB >> 29752393

Cardiac Structural Remodeling, Longitudinal Systolic Strain, and Torsional Mechanics in Lean and Nonlean Dysglycemic Chinese Adults.

Jiun-Lu Lin1,2, Kuo-Tzu Sung1,3, Cheng-Huang Su1,3, Tzu-Hsun Chou, Chi-In Lo1,3, Jui-Peng Tsai1,3, Shun-Chuan Chang1, Yau-Huei Lai4, Kuang-Chun Hu5,6, Chia-Yuan Liu5,6, Chun-Ho Yun5,7, Chung-Lieh Hung8,3,9,10, Hung-I Yeh3, Carolyn S P Lam11,12.   

Abstract

BACKGROUND: Diabetes mellitus and pre-diabetes mellitus are associated with lower body mass indices and increased risk of cardiovascular events (including heart failure) at lower glucose thresholds in Chinese compared with Western cohorts. However, the extent of cardiac remodeling and regulation on cardiac mechanics in lean and nonlean dysglycemic Chinese adults is understudied. METHODS AND
RESULTS: We studied 3950 asymptomatic Chinese (aged 49.7±10.7 years; 65% male; body mass index: 24.3±3.5 kg/m2) with comprehensive echocardiography including speckle tracking for left ventricular global longitudinal strain/torsion, with plasma sugar, glycosylated hemoglobin (HbA1c), and insulin resistance (homeostasis model assessment of insulin resistance) obtained. Participants were classified as (1) nondiabetic (fasting glucose <100 mg/mL; HbA1c <5.7%; n=1416), prediabetic (fasting glucose 100-126 mg/dL; HbA1c 5.7%-6.4%; n=2029), or diabetic (n=505) and (2) lean (body mass index <23 kg/m2; n=1445) or nonlean (n=2505). Higher sugar, HbA1c, and homeostasis model assessment of insulin resistance were independently associated with higher left ventricular mass, greater mass-to-volume ratio, more impaired diastolic indices, and worse global longitudinal strain even after adjusting for clinical covariates (adjusted coefficient value: 0.28/0.12 for global longitudinal strain per 1 U HbA1c/homeostasis model assessment of insulin resistance increment; both P<0.001), with a consistent trend toward greater torsion (all trend P<0.001). The optimal cutoffs in identifying subclinical systolic dysfunction (global longitudinal strain more impaired than -18%) for lean versus nonlean individuals were 97 versus 106 mg/dL for fasting sugar, 130 versus 135 mg/mL for postprandial sugar, 5.62% versus 6.28% for HbA1c, and 1.81 versus 2.40 for homeostasis model assessment of insulin resistance, respectively.
CONCLUSIONS: These data demonstrate the presence of preclinical cardiac remodeling and systolic dysfunction in prediabetic and diabetic Chinese adults, occurring at lower thresholds of glycemic indices than defined by international standards, particularly in lean individuals.
© 2018 American Heart Association, Inc.

Entities:  

Keywords:  cardiomyopathy; diabetes mellitus; glucose; heart failure; insulin resistance

Mesh:

Substances:

Year:  2018        PMID: 29752393     DOI: 10.1161/CIRCIMAGING.117.007047

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  4 in total

1.  [Changes of two-pore K+ channel TASK-1 in diabetic myocardial injury in rats].

Authors:  Heng Zhang; Min Tao; Pinfang Kang; Jianlu Guo; Ling Xuan; Bi Tang; Qin Gao; Hongju Wang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-09-30

2.  Diabetes Attenuates the Contribution of Endogenous Nitric Oxide but Not Nitroxyl to Endothelium Dependent Relaxation of Rat Carotid Arteries.

Authors:  Jasmin Chendi Li; Anida Velagic; Cheng Xue Qin; Mandy Li; Chen Huei Leo; Barbara K Kemp-Harper; Rebecca H Ritchie; Owen L Woodman
Journal:  Front Pharmacol       Date:  2021-01-21       Impact factor: 5.810

Review 3.  Epidemiology of heart failure.

Authors:  Amy Groenewegen; Frans H Rutten; Arend Mosterd; Arno W Hoes
Journal:  Eur J Heart Fail       Date:  2020-06-01       Impact factor: 15.534

4.  The Systolic and Diastolic Cardiac Function of Patients With Type 2 Diabetes Mellitus: An Evaluation of Left Ventricular Strain and Torsion Using Conventional and Speckle Tracking Echocardiography.

Authors:  Qing-Mei Yang; Jian-Xiu Fang; Xiao-Yan Chen; Hong Lv; Chun-Song Kang
Journal:  Front Physiol       Date:  2022-01-07       Impact factor: 4.566

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.